FDA Experts To Convene For March Panel To Discuss Dermal Fillers
The US agency will hold a meeting of its plastic surgery devices panel to discuss risks associated with, and patient preference for, dermal fillers.
You may also be interested in...
Moderna’s COVID-19 vaccine got a more solid ‘yes’ vote than Pfizer/BioNTech’s, but committee chair cautions against drawing any comparisons between the products from the different tallies. Last-minute bickering over FDA’s phrasing of voting question complicated meeting but resulted in minimal harm.
FDA urged dermal filler firms to update labeling to warn of rare but serious complications that can occur when the soft tissue products are unintentionally injected into facial blood vessels in conjunction with a safety communication to providers and patients on the topic.
A former Army ranger, Michael Minogue wants to help military veterans transition into and gain employment opportunities in the medtech industry.